{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T05:36:08Z","timestamp":1737956168072,"version":"3.33.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,26]]},"DOI":"10.7759\/cureus.78004","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T16:43:07Z","timestamp":1737909787000},"source":"Crossref","is-referenced-by-count":0,"title":["Pleural Effusion in a Patient With Chronic Myelomonocytic Leukemia Treated With Azacitidine"],"prefix":"10.7759","author":[{"given":"Marwa","family":"Mir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bella","family":"Gnakou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akila","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia Yi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wajeeha","family":"Aiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid S","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunwant","family":"Guron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.125.4.1546","article-title":"Pleural effusions in hematologic malignancies","volume":"125","author":"Alexandrakis MG","year":"2004","unstructured":"Alexandrakis MG, Passam FH, Kyriakou DS, Bouros D. Pleural effusions in hematologic malignancies. Chest. 2004, 125:1546-55. 10.1378\/chest.125.4.1546","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00279-2020","article-title":"Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors","volume":"56","author":"Weatherald J","year":"2020","unstructured":"Weatherald J, Bondeelle L, Chaumais MC, et al.. Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors. Eur Respir J. 2020, 56:2000279. 10.1183\/13993003.00279-2020","journal-title":"Eur Respir J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2021.279500","article-title":"How I diagnose and treat chronic myelomonocytic leukemia","volume":"107","author":"Patnaik MM","year":"2022","unstructured":"Patnaik MM. How I diagnose and treat chronic myelomonocytic leukemia. Haematologica. 2022, 107:1503-17. 10.3324\/haematol.2021.279500","journal-title":"Haematologica"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4103\/0970-9371.97165","article-title":"Pleural effusion as the initial manifestation of chronic myeloid leukemia: report of a case with clinical and cytologic correlation","volume":"29","author":"Nuwal P","year":"2012","unstructured":"Nuwal P, Dixit R, Dargar P, George J. Pleural effusion as the initial manifestation of chronic myeloid leukemia: report of a case with clinical and cytologic correlation. J Cytol. 2012, 29:152-4. 10.4103\/0970-9371.97165","journal-title":"J Cytol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/OAEM.S29942","article-title":"Pleural effusion: diagnosis, treatment, and management","volume":"4","author":"Karkhanis VS","year":"2012","unstructured":"Karkhanis VS, Joshi JM. Pleural effusion: diagnosis, treatment, and management. Open Access Emerg Med. 2012, 4:31-52. 10.2147\/OAEM.S29942","journal-title":"Open Access Emerg Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/MCP.0000000000000060","article-title":"Pleural effusions in acute and chronic leukemia and myelodysplastic syndrome","volume":"20","author":"Faiz SA","year":"2014","unstructured":"Faiz SA, Sahay S, Jimenez CA. Pleural effusions in acute and chronic leukemia and myelodysplastic syndrome. Curr Opin Pulm Med. 2014, 20:340-6. 10.1097\/MCP.0000000000000060","journal-title":"Curr Opin Pulm Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236008","article-title":"Cytokines in inflammatory disease","volume":"20","author":"Kany S","year":"2019","unstructured":"Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019, 20:6008. 10.3390\/ijms20236008","journal-title":"Int J Mol Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S51800","article-title":"Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes","volume":"7","author":"Mughal TI","year":"2014","unstructured":"Mughal TI, Vaddi K, Sarlis NJ, Verstovsek S. Myelofibrosis-associated complications: pathogenesis, clinical manifestations, and effects on outcomes. Int J Gen Med. 2014, 7:89-101. 10.2147\/IJGM.S51800","journal-title":"Int J Gen Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-023-03531-z","article-title":"Dasatinib for chronic myelomonocytic leukemia with ZMIZ1-ABL1 fusion gene: a case report","volume":"117","author":"Liu H","year":"2023","unstructured":"Liu H, Bai H, Zhang S, Zhao X, Mao D, Xi R. Dasatinib for chronic myelomonocytic leukemia with ZMIZ1-ABL1 fusion gene: a case report. Int J Hematol. 2023, 117:929-32. 10.1007\/s12185-023-03531-z","journal-title":"Int J Hematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.82","article-title":"Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance","volume":"6","author":"Patnaik MM","year":"2016","unstructured":"Patnaik MM, Zahid MF, Lasho TL, et al.. Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance. Blood Cancer J. 2016, 6:e472. 10.1038\/bcj.2016.82","journal-title":"Blood Cancer J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/imj.13991","article-title":"Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience","volume":"48","author":"Loveland P","year":"2018","unstructured":"Loveland P, Christie M, Hammerschlag G, Irving L, Steinfort D. Diagnostic yield of pleural fluid cytology in malignant effusions: an Australian tertiary centre experience. Intern Med J. 2018, 48:1318-24. 10.1111\/imj.13991","journal-title":"Intern Med J"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2009.006080","article-title":"Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance","volume":"94","author":"Barrett JA","year":"2009","unstructured":"Barrett JA, Sloand E. Autoimmune mechanisms in the pathophysiology of myelodysplastic syndromes and their clinical relevance. Haematologica. 2009, 94:449-51.","journal-title":"Haematologica"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/294140-pleural-effusion-in-a-patient-with-chronic-myelomonocytic-leukemia-treated-with-azacitidine","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T16:43:09Z","timestamp":1737909789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/294140-pleural-effusion-in-a-patient-with-chronic-myelomonocytic-leukemia-treated-with-azacitidine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,26]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.78004","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,26]]}}}